関連する実験動画
Updated: Feb 20, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.9K
子どもと青年の肥満
Casey Berman1, Brenda Kohn1, Don Wilson2
1NYU Langone Health, New York, NY, USA (Drs Berman and Kohn).
Journal of clinical lipidology
|February 18, 2026
まとめ
幼児の肥満は,子供や青少年に影響を与える流行病である. 管理には,予防と高リスクの個人に焦点を当て,集中的な健康行動とライフスタイル治療 (IHBLT),手術,または薬理学的治療法を使用するユニークなアプローチが必要です.
科学分野:
- 小児科は小児科です.
- 公衆衛生は公衆衛生である.
- エンドクリノロジー エンドクリノロジー
背景:
- 米国は,成人と小児の両方に影響を与える重大な肥満の流行に直面しています.
- 小児肥満は慢性疾患であり,罹患率が増加しています.
研究 の 目的:
- 小児肥満に関する現在の定義と勧告をレビューする.
- 大人と比較して子供の肥満のユニークな側面,危険因子,影響について議論する.
主な方法:
- 85件の論文に関する広範な文献レビューが行われました.
- このレビューでは,定義,流行,リスク要因,管理戦略に関する情報をまとめました.
主要な成果:
- 幼児の肥満は,進行と管理においてユニークな課題を提示します.
- 重要な管理戦略には,集中的な健康行動およびライフスタイル治療 (IHBLT),代謝外科手術,およびグルカゴン型のペプチド-1受容体アゴニスト (GLP-1RAs) のような薬理学的療法が含まれています.
結論:
- 幼児の肥満は,予防に焦点を当てた明確なアプローチを必要とします.
- 経営陣は,高リスクの個人を優先し,対応策を策定すべきである.
関連する概念動画
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients
279
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
279
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
302
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302
Bulimia Nervosa
837
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
837
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
208
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
208
Signs of Puberty
1.6K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.6K

